Temozolomide treatment in glioma--experiences in two university hospitals in Finland.

about

Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas.

P2860

Q33973844-75897E58-A3DB-42E7-A4C5-99400032B1D1

P2860

Temozolomide treatment in glioma--experiences in two university hospitals in Finland.

Item

http://www.wikidata.org/entity/Q45061240

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Temozolomide treatment in glioma--experiences in two university hospitals in Finland.

@en

Temozolomide treatment in glioma--experiences in two university hospitals in Finland.

@nl

type

Item

label

Temozolomide treatment in glioma--experiences in two university hospitals in Finland.

@en

Temozolomide treatment in glioma--experiences in two university hospitals in Finland.

@nl

prefLabel

Temozolomide treatment in glioma--experiences in two university hospitals in Finland.

@en

Temozolomide treatment in glioma--experiences in two university hospitals in Finland.

@nl

P1476

Temozolomide treatment in glioma--experiences in two university hospitals in Finland

@en

P2093

Hanna O Mäenpää

http://www.w3.org/2001/XMLSchema#string

Kirsimari Aaltonen

http://www.w3.org/2001/XMLSchema#string

Riitta Mäntylä

http://www.w3.org/2001/XMLSchema#string

P2860

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse.

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.

Phase II study of temozolomide in patients with relapsing high grade glioma and poor performance status.

Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies

Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy.

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide.

Phase II trial of temozolomide in patients with progressive low-grade glioma.

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

Chemotherapy for high-grade gliomas.

Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group.

P304

579-584

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/02841860410015271

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Heikki Minn

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8343506

http://www.w3.org/2001/XMLSchema#string

P698

15370616

http://www.w3.org/2001/XMLSchema#string

P921

Finland

Temozolomide treatment in glioma--experiences in two university hospitals in Finland.

about

P2860

P2860

Temozolomide treatment in glioma--experiences in two university hospitals in Finland.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921